Jun 18, 2012, 03.24 PM | Source: Moneycontrol.com
Piramal Healthcare is in talk to buy US based healthcare company called Cambridge Major Labs for USD 200 million, reports Business Line.
Piramal Healthcare touched an intraday high of Rs 492 and an intraday low of Rs 481. At 09:59 hrs the share was quoting at Rs 490, up Rs 4.50, or 0.93%.
It was trading with volumes of 3,542 shares. In the previous trading session, the share closed up 3.13% or Rs 14.75 at Rs 485.50.
The company's trailing 12-month (TTM) EPS was at Rs 20.75 per share. (Mar, 2012). The stock's price-to-earnings (P/E) ratio was 23.57. The latest book value of the company is Rs 685.56 per share. At current value, the price-to-book value of the company was 0.71. The dividend yield of the company was 2.45%.
Piramal Enterprises' Q3 results on February 08, 2016
Piramal Enterprises Ltd has informed BSE that a me
Piramal Enterprises: Outcome of committee meeting
Piramal Enterprises has informed that at the Meeti
Piramal Enterprises announces sale of BST-CarGel
Through this transaction, an affiliate of Smith &
Piramal gets director panel nod to raise up to Rs 500 cr
The committee of directors (funding) has approved
US, India in talks to settle solar power trade dispute
Washington filed the WTO challenge three years ago
Proposed oil tax can be a good thing for US economy: Obama
"We're going to impose a tax on a barrel of oil im
Industrialists attend 'Make in India Week' seminar in US
The Illinois Chief Information Officer Hardik Bhat
India is our largest market outside US: Domino's Pizza's Boss
J Patrick Doyle, President and CEO, Domino's Pizza